ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

Description

Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks

Conditions

Lung Cancer, Gastrointestinal Cancer, Head and Neck Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

Evaluate the feasibility of using a chatbot combined with continuous activity monitoring to proactively identify, appropriately triage and help manage patients' symptoms during cancer treatment Determine whether such an early outpatient clinic-based intervention can decrease rates of excess triage visits Correlate changes in activity and early symptom management to emergency department visits, unplanned inpatient hospitalizations and treatment breaks

Use of Natural Language Processing ChatBot and Automated Continuous Activity Monitoring Via Mobile Phones for Early Detection and Management of Symptoms in Patients Undergoing Cancer Treatment

ChatBot and Activity Monitoring in Patients Undergoing Chemoradiotherapy

Condition
Lung Cancer
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adults (age \>18 years) with a diagnosis of a head and neck, lung, gastrointestinal cancer, that are receiving concurrent chemotherapy and radiation treatment.
  • * Possession of a mobile device that can receive SMS texts and can deliver FitBit data wirelessly
  • * Ability read and respond in English
  • * Ability to provide informed consent to participate in the study
  • * Patients who are bed bound at baseline (ECOG 4)
  • * Patients who rely on a wheelchair for ambulation

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Abramson Cancer Center at Penn Medicine,

Arun Goel, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Kristine Kim, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Nishant Shah, MD, PRINCIPAL_INVESTIGATOR, University of Pennsylvania

Study Record Dates

2025-05